| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $214.2M | +52.1% |
| Cost of Revenue | $34.4M | +57.2% |
| R&D Expense | $19.8M | +16.8% |
| SG&A Expense | $58.2M | +17.2% |
| Operating Income | $101.8M | +94.4% |
| Pre-tax Income | $104.7M | +98.8% |
| Income Tax | $21.6M | +64.1% |
| Net Income | $83.1M | +110.4% |
| EPS (Basic) | $0.80 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $298.4M | +74.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $10.4M | +57.7% |
| Inventory | $6.8M | -13.5% |
| Current Assets | $320.8M | +52.7% |
| Total Assets | $375.6M | +58.0% |
| Current Liabilities | $57.6M | +112.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $116.0M | +92.2% |
| Capital Expenditures | $29K | -97.2% |
| Investing Cash Flow | $9.2M | +183.6% |
| Financing Cash Flow | $1.7M | +120.8% |
| Free Cash Flow | $116.0M | +95.5% |
| +110.5% |
| EPS (Diluted) | $0.75 | +102.7% |
| Total Liabilities |
| $75.2M |
| +142.9% |
| Stockholders' Equity | $300.4M | +45.2% |